Operating Lease, Right-of-Use Asset of Corbus Pharmaceuticals Holdings, Inc. from 02 Jan 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Corbus Pharmaceuticals Holdings, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 02 Jan 2019 to 31 Dec 2025.
  • Corbus Pharmaceuticals Holdings, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $1,082,000, a 49% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Corbus Pharmaceuticals Holdings, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,082,000 -$1,051,000 -49% 31 Dec 2025 10-K 09 Mar 2026 2025 FY
Q3 2025 $1,357,000 -$1,020,000 -43% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $1,624,000 -$988,000 -38% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 $1,882,000 -$959,189 -34% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 $2,133,000 -$930,000 -30% 31 Dec 2024 10-K 09 Mar 2026 2025 FY
Q3 2024 $2,377,000 -$900,943 -27% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $2,612,000 -$874,416 -25% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 $2,841,189 -$847,279 -23% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $3,063,000 -$821,252 -21% 31 Dec 2023 10-K 11 Mar 2025 2024 FY
Q3 2023 $3,277,943 -$796,131 -20% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $3,486,416 -$771,661 -18% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $3,688,468 -$747,908 -17% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $3,884,252 -$724,858 -16% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $4,074,074 -$702,497 -15% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $4,258,077 -$680,812 -14% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $4,436,376 -$659,789 -13% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $4,609,110 -$639,415 -12% 31 Dec 2021 10-K 07 Mar 2023 2022 FY
Q3 2021 $4,776,571 -$619,677 -11% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $4,938,889 -$600,788 -11% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $5,096,165 -$584,302 -10% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $5,248,525 -$570,458 -9.8% 31 Dec 2020 10-K 08 Mar 2022 2021 FY
Q3 2020 $5,396,248 -$173,751 -3.1% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $5,539,677 -$156,012 -2.7% 30 Jun 2020 10-Q/A 31 Aug 2020 2020 Q2
Q1 2020 $5,680,467 -$158,968 -2.7% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $5,818,983 +$3,418,983 +142% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 $5,569,999 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 $5,695,689 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $5,839,435 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $2,400,000 02 Jan 2019 10-Q 09 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.